We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.49%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.3B
AUM Growth
+$91M
Cap. Flow
-$6.54M
Cap. Flow %
-0.5%
Top 10 Hldgs %
34.31%
Holding
270
New
10
Increased
44
Reduced
91
Closed
6

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$1.24M
2
ON icon
ON Semiconductor
ON
+$940K
3
SYK icon
Stryker
SYK
+$884K
4
OGN icon
Organon & Co
OGN
+$748K
5
DE icon
Deere & Co
DE
+$623K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.69M
2
QCOM icon
Qualcomm
QCOM
+$1.55M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$1.46M
4
VEEV icon
Veeva Systems
VEEV
+$1.36M
5
AAPL icon
Apple
AAPL
+$967K

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Healthcare 18.34%
3 Financials 15.25%
4 Industrials 11.71%
5 Communication Services 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDS.A
126
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$994K 0.08%
24,600
– –
TT icon
127
Trane Technologies
TT
$106B
$979K 0.08%
5,315
+1,670
+46% +$298K
CMCSA icon
128
Comcast
CMCSA
$90B
$972K 0.07%
17,045
+2,333
+16% +$130K
SLB icon
129
SLB Ltd
SLB
$75B
$970K 0.07%
30,297
– –
FTV icon
130
Fortive
FTV
$18.6B
$949K 0.07%
18,058
-2,123
-11% -$114K
NVS icon
131
Novartis
NVS
$297B
$906K 0.07%
9,932
– –
SYK icon
132
Stryker
SYK
$130B
$898K 0.07%
+3,458
New +$884K
NUE icon
133
Nucor
NUE
$62.1B
$868K 0.07%
9,044
-50
-0.5% -$4.68K
GWW icon
134
W.W. Grainger
GWW
$60.2B
$867K 0.07%
1,979
– –
SLRC icon
135
SLR Investment Corp
SLRC
$715M
$867K 0.07%
46,500
– –
COF icon
136
Capital One
COF
$134B
$844K 0.07%
5,455
– –
CET
137
Central Securities Corp
CET
$1.65B
$820K 0.06%
19,428
-1,000
-5% -$40.4K
BKU icon
138
Bankunited
BKU
$3.36B
$818K 0.06%
19,165
-175
-0.9% -$7.99K
DOV icon
139
Dover
DOV
$28.4B
$803K 0.06%
5,332
– –
KNX icon
140
Knight Transportation
KNX
$11.4B
$777K 0.06%
17,100
– –
ENB icon
141
Enbridge
ENB
$112B
$773K 0.06%
19,290
– –
ROP icon
142
Roper Technologies
ROP
$39.8B
$772K 0.06%
1,642
-78
-5% -$34.5K
HPQ icon
143
HP
HPQ
$27.5B
$732K 0.06%
24,250
– –
FCX icon
144
Freeport-McMoran
FCX
$97.5B
$705K 0.05%
19,009
– –
EQR icon
145
Equity Residential
EQR
$25.1B
$693K 0.05%
9,000
– –
OGN icon
146
Organon & Co
OGN
$3.57B
$688K 0.05%
+22,738
New +$748K
TD icon
147
Toronto Dominion Bank
TD
$200B
$687K 0.05%
9,815
– –
WMB icon
148
Williams Companies
WMB
$86.1B
$683K 0.05%
25,743
– –
FDX icon
149
FedEx
FDX
$75.4B
$682K 0.05%
2,285
+240
+12% +$71.2K
DOW icon
150
Dow Inc
DOW
$21.2B
$676K 0.05%
10,681
– –
4 5
6
7 8

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2021 Portfolio in Review

As of Q2 2021, Neville Rodie & Shaw held 270 positions worth $1.3B, up 7.5% from $1.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Neville Rodie & Shaw's Q2 2021 filing shows 10 new, 44 increased, 91 reduced and 6 closed positions. Its largest new stake was Stryker: 3,458 shares worth $898K. The largest sale was Merck, an estimated $1.69M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q2 2021 buy was Stryker: 3,458 shares worth $898K.
  • Neville Rodie & Shaw added most to Morgan Stanley in Q2 2021, an estimated $1.24M increase.
  • Neville Rodie & Shaw's biggest Q2 2021 reduction was Merck, cutting an estimated $1.69M.
  • Neville Rodie & Shaw fully exited Veeva Systems in Q2 2021, selling an estimated $1.36M.
  • Neville Rodie & Shaw's ten largest holdings make up 34% of its $1.3B portfolio in Q2 2021.
  • Neville Rodie & Shaw opened 10 new positions and closed 6 in Q2 2021.
  • Neville Rodie & Shaw's portfolio value rose 7.5% quarter-over-quarter to $1.3B.

Based on Neville Rodie & Shaw's 13F filing for Q2 2021, filed 6 Jul 2021.